The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women

Acta Cardiologica

Volumn 59, Issue 6, 2004, Pages 618-622

  Letonja, Mitja ^a  

^a General Hospital Ptuj   (Slovenia)

Author keywords

Caucasian woman; Coronary artery disease; eNOS gene polymorphism; Lipids

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; POLYMERASE CHAIN REACTION; PREMATURITY; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPOPROTEINS; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 10244264742     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.59.6.2005244     Document Type: Article

References (28)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
2. Wang Y, Mardsen PA. Nitric oxide synthases: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995; 4: 12-22.
3. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
4. Quyyumi AA, Dakak N, Andrevs NP, Husian S, Arora S, Gilligan DM, Panza JA, Canon RO III. Nitric oxide activity in human coronary circulation. J Clin Invest 1995; 95: 1747-55.
5. Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992; 86: 1302-9.
6. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88: 4651-5.
7. Garg UC, Hassid A. Nitric oxide-generating vasodilatators and 8- bromocycic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7.
8. Hogg N, Kalyaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 1993; 334: 170-4.
9. Mardsen PA, Heng HH, Scherer SW. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
10. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996; 2: 41-5.
11. Hibi K, Isigami T, Tamura K, Shunsaku M, Nyui N, Fujita T, Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-62.
12. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, Whitsett C, Rawlins P, Evatt BL. The relationship between polymorphism in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999; 116: 880-6.
13. Sigusch HH, Surber R, Lehmann MH, Surber S, Weber J, Henke A, Reinhardt D, Hoffman A, Figulla HR. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scan J Clin Lab Invest 2000; 60: 229-35.
14. Petrovic D, Zorc M, Peterlin B. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease. Folia Biol (Praha) 2000; 46: 181-5.
15. Petrovic D, Peterlin B. Estrogen receptor dinucleotide (TA) polymorphism does not predict premature myocardial infarction in Caucasian women. Cardiology 2003; 99: 163-5.
16. Ichiara S, Yamada Y, Fujimara T, Nakashima N, Yokota M. Association of a polymorphism of endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81: 83-6.
17. Cine N, Hatemi AC, Erginel-Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin Genet 2002; 61: 66-70.
18. Via M, Lopez-Alomar A, Valveny N, Gonzalez-Perez, Pedro M. Lack of association between eNOS gene polymorphism and ischemic heart disease in the Spanish population. Am J Med Gen 2003; 116A: 243-8.
19. Yoon Y, Song J, Hong HS, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626-30.
20. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000; 78: 372-9.
21. Gardermann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosh W. The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic profile. Atherosclerosis 2002; 160: 167-75.
22. Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 2000; 150: 179-85.
23. Granath B, Taylor RR, Bockxmeer FM van, Mamotte CD. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Australian Caucasian population. J Cardiovasc Risk 2001; 8: 235-41.
24. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190-3.
25. Wang XL, Mahaney MC, Sim AS, Wang J, Blancero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the nitric oxide synthase gene to plasma nitric oxide level. Atheroscler Thromb Vasc Biol 1997; 17: 3147-53.
26. Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology 2001; 52: 247-52.
27. Petrovic D, Globocnik-Petrovic M, Peterlin B. 4G4G genotype of PAI-1 gene promoter polymorphism is not associated with myocardial infarction in Caucasians with type-2 diabetes. Cardiology 2003; 100: 157-8.
28. Petrovic D, Zorc M, Keber I, Peterlin B. Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353) gene polymorphism on the risk of premature coronary artery disease. Ann Genet 2001; 44: 33-6.